Carregant...
Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
OBJECTIVE: Second-generation antipsychotics (SGAs) have a high risk of causing metabolic syndrome (MetS). There is accumulating evidence supporting the fact that the activation of inflammatory pathway contributes to the development of MetS and further aggravates cognitive impairment. This study aime...
Guardat en:
| Publicat a: | Neuropsychiatr Dis Treat |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681158/ https://ncbi.nlm.nih.gov/pubmed/31534339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S202159 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|